Taysha Gene Therapies
TSHA
TSHA
52 hedge funds and large institutions have $43.8M invested in Taysha Gene Therapies in 2022 Q4 according to their latest regulatory filings, with 14 funds opening new positions, 21 increasing their positions, 9 reducing their positions, and 16 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
less ownership
Funds ownership: →
4% less funds holding
Funds holding: 54 → 52 (-2)
13% less first-time investments, than exits
New positions opened: 14 | Existing positions closed: 16
Holders
52
Holding in Top 10
–
Calls
$189K
Puts
$85K
Top Buyers
| 1 | +$3.14M | |
| 2 | +$2.26M | |
| 3 | +$1.92M | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$1.1M |
| 5 |
AG
Artal Group
Luxembourg
|
+$904K |
Top Sellers
| 1 | -$727K | |
| 2 | -$207K | |
| 3 | -$183K | |
| 4 |
Two Sigma Advisers
New York
|
-$169K |
| 5 |
State of Wisconsin Investment Board
Madison,
Wisconsin
|
-$167K |